Voices
Charlotte Kuperwasser: How Morning vs Afternoon Immunotherapy Can Cut Lung Cancer Risk
Charlotte Kuperwasser

Charlotte Kuperwasser: How Morning vs Afternoon Immunotherapy Can Cut Lung Cancer Risk

Charlotte Kuperwasser, Professor, Scientist, Co-Founder shared a post on LinkedIn:

“Morning vs afternoon immunotherapy cut the risk of cancer progression and death by ~60% in lung cancer!!! An amazing phase 3 randomized trial shows that the time of day immunotherapy is given can meaningfully change outcomes in advanced non–small cell lung cancer.

This finding points to the importance of circadian rhythms in shaping immune function, metabolism, and treatment response.

As precision medicine advances, it’s worth asking whether some of the variability we attribute to “biology” is actually coming from systems we haven’t been paying attention to.”

Title: Time-of-day immunochemotherapy in non small cell lung cancer: a randomized phase 3 trial

Authors: Zhe Huang, Liang Zeng, Zhaohui Ruan, Qun Zeng, Huan Yan, Wenjuan Jiang, Yi Xiong, Chunhua Zhou, Haiyan Yang, Li Liu, Jiacheng Dai, Nachuan Zou, Shidong Xu, Ya Wang, Zhan Wang, Jun Deng, Xue Chen, Jing Wang, Hua Xiang, Xiaomei Li, Boris Duchemann, Guoqiang Chen, Yang Xia, Tony Mok, Christoph Scheiermann, Francis Lévi, Nong Yang, Yongchang Zhang

Read The Full Article on Nature Medicine

Charlotte Kuperwasser

Give me title idea start with Lung Cancer on OncoDaily.

 

 

Boris Duchemann cancer Charlotte Kuperwasser Christoph Scheiermann Chunhua Zhou Francis Lévi Guoqiang Chen Haiyan Yang Hua Xiang Huan Yan immunotherapy Jiacheng Dai Jing Wang Jun Deng Li Liu Liang Zeng Lung cancer Nachuan Zou Nong Yang OncoDaily Oncology Qun Zeng Shidong Xu Tony Mok Wenjuan Jiang Xiaomei Li Xue Chen Ya Wang Yang Xia Yi Xiong Yongchang Zhang Zhan Wang Zhaohui Ruan Zhe Huang